Press Release MJWire - Investing In Marijuana

PR - Medican Enterprises Closes Acquisition of CBD Branding Company TWYNS in All Stock Deal

LAS VEGAS–(BUSINESS WIRE)–Medican Enterprises Inc. (OTCBB:MDCN) (“Medican” or “the Company”), a merchant bank and bio-pharmaceutical company in the emerging global marijuana industry, announces that further to its press release of April 28, 2014 the Company has closed on its acquisition of TWYNS, a company that provides branding services for enterprises in the Cannabidiol (CBD) business. The transaction is valued at approximately $1,000,000, all in stock and is expected to add approximately $400,000 to Medican’s annual revenues.

TWYNS business plan extends the sale of CBD to more consumers globally through strategic branding,” stated Ken Williams, CEO of Medican Enterprises. “The model is Coca-Cola’s very successful bottling distributing arrangement. We believe that cannabis will be a cottage industry for the foreseeable future, with each regulated jurisdiction demanding fees and licenses. TWYNS will provide local growers, product manufacturers and distributors with a reliable ‘seal of approval’ that ensures quality and provides the consumer with a reliable benchmark.”

PR - Saratoga's Wholly-Owned Subsidiary Abba Medix Signs Letter of Intent to Acquire Redecan

April 06, 2015 09:03 ET

Saratoga's (CSE:ABA) Wholly-Owned Subsidiary Abba Medix Signs Letter of Intent to Acquire Redecan, a Health Canada MMPR Licensed Producer, for CDN $11,000,000 in Cash and Shares.
TORONTO, ONTARIO--(Marketwired - April 6, 2015) - Abba Medix Corp., ("Abba Medix", a wholly-owned subsidiary of Saratoga Electronic Solutions Inc., "Saratoga", or the "Company") (CSE:ABA) is pleased to report that it has entered into a Letter of Intent with 9037136 Canada Inc., operating and known as Redecan Pharm ("Redecan"), a Health Canada licensed producer and distributor of medical marijuana.
Redecan is focused on developing premium quality medical marijuana products and is a licensed producer and seller, able to cultivate marijuana under the Marihuana for Medical Purposes Regulations ("MMPR") in Canada.

The principal focus of Redecan is the production of marijuana from its fully-secured, 15,000 square foot greenhouse production facility in Niagara, Ontario. Redecan obtained a medical marijuana license to undertake the production of medical marijuana in July 2014, and in March 2015 was awarded its sales license. Abba Medix and Redecan shall review, count, and determine the value of Redecan's product inventory immediately following the Closing. Redecan estimates that there is currently 114.7kg of product inventory.

PR - United Treatment Centers, Inc. Appoints New Management Team at PotNetwork Inc.

PotNetwork Reveals Corporate Strategy

United Treatment Centers, Inc. (OTC PINK: UTRM) is pleased to announce that the Company has appointed three new key executives at PotNetwork Incorporated; a wholly owned subsidiary of United Treatment Centers Inc. Richard Volpe has been appointed as the Company’s Chief Executive Officer, Keith Levinson as President, and Lane Tyler Radbill, as the Vice President of Content Development. “I am pleased with the accomplishments that we have achieved in such a short time, I look forward to the team we have appointed executing their business plan they have set forth; in addition we are pleased to report that we are continuing our relationship with Neovix Inc., our streaming video provider.” said Steven Buckner CEO of United Treatment Centers Inc.

PR - Inergetics Launch Event for First Branded Cannabidiol (CBD) Based Supplement Offering Natural Pain Relief

Launch Event for First Branded Cannabidiol (CBD)-Based Supplement Offering Natural Pain Relief From Inergetics

NEW YORK, March 23, 2015 /PRNewswire/ -- The first branded Cannabidiol (CBD)-based nutraceutical product offering natural pain relief will be launched by Inergetics, Inc. (OTC-BB: NRTI), a world-class consumer health and wellness company dedicated to bringing a suite of "farm to formula" products to market.